This decision should be based on clinical evidence, genetic context, and individual goals rather than guesswork
As a 2022 report noted, "obesity remains the most important risk factor for the incidence and progression of osteoarthritis." According to Bliddal, the researchers launched the study to answer this question: "Would a highly effective anti-obesity medication improve KOA to a clinically meaningful degree?" Other studies had tackled the question with inconsistent results, he said
This transforms topical GHK-Cu application from a cosmetically limited surface treatment into a clinically relevant dermal intervention
Athletes and others recovering from surgery may find BPC-157 interesting, as it has also been studied for its potential to accelerate muscle recovery and repair of tendon damage
Label with date reconstituted
its a bold step in addressing one of the most pressing public health challenges - obesity